Analysis

Notre Dame law student analyzes the “Obamacare” ruling

Adding to the discussion.

Notre Dame law student and former Life Report guest John Gerardi joins Josh Brahm and Jonathan Keller in the studio to discuss the Supreme Court’s “ObamaCare” decision. Josh opens the show by focusing on how this legislation promotes abortion and tramples on religious liberty. This includes a brief explanation of why “ella” should definitively be considered an abortifacient, and not merely a contraceptive. Josh also discourages people from making baseless claims about Chief Justice Roberts’ intelligence or intentions.

Afterwards, John Gerardi gives a careful analysis of the decision, including what constitutional issues were examined.  The show ends with a discussion of what pro-lifers can do to fix things.

Download Audio MP3 | 00:28:00

[youtube http://www.youtube.com/watch?v=SZibCxThQxU&version=3&hl=en_US]

Note from Josh: After this episode finished shooting, we stayed on the air for over an hour continuing the discussion and responding to questions from our live stream audience. We will be releasing that footage in sections over the next week or two, so keep checking ProLifePodcast.net for regular updates, or subscribe to our RSS feed.

Related Links:

  • Download the article Josh referenced on the effects of progesterone antagonists like Ella: “Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications”  (HT Rich Poupard @ Life Training Institute.)
  • Watch other episodes of Life Report on ObamaCare.

What is Live Action News?

Live Action News is pro-life news and commentary from a pro-life perspective. Learn More

Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.

GUEST ARTICLES: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated. (See here for Open License Agreement.) Thank you for your interest in Live Action News!



To Top